133 related articles for article (PubMed ID: 34957622)
1. Categorisation of lymph node aspirates using the proposed Sydney system with assessment of risk of malignancy and diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Jul; 33(4):430-438. PubMed ID: 34957622
[TBL] [Abstract][Full Text] [Related]
2. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of Thinprep® in cervical lymph node aspiration: Assessment according to the Sydney system.
Uzun E; Erkilic S
Diagn Cytopathol; 2022 May; 50(5):253-262. PubMed ID: 35148033
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of accuracy of salivary gland fine needle aspirates using the Milan System for Reporting Salivary Gland Cytopathology.
Ahuja S; Malviya A
Cytopathology; 2022 Jul; 33(4):463-471. PubMed ID: 35385174
[TBL] [Abstract][Full Text] [Related]
5. Assessment of risk of malignancy by application of the proposed Sydney system for classification and reporting lymph node cytopathology.
Gupta P; Gupta N; Kumar P; Bhardwaj S; Srinivasan R; Dey P; Rohilla M; Bal A; Das A; Rajwanshi A
Cancer Cytopathol; 2021 Sep; 129(9):701-718. PubMed ID: 33830657
[TBL] [Abstract][Full Text] [Related]
6. The Application of the Proposed Sydney System for Reporting Lymph Node Cytopathology: A Five-Year Experience of an Academic Institution in South India.
Shanmugasundaram S; Balasubramanian NB; Sundari Amirthakatesan A
Acta Cytol; 2023; 67(4):365-377. PubMed ID: 36917967
[TBL] [Abstract][Full Text] [Related]
7. Categorization of Breast Fine Needle Aspirates Using the International Academy of Cytology Yokohama System Along with Assessment of Risk of Malignancy and Diagnostic Accuracy in a Tertiary Care Centre.
Ahuja S; Malviya A
J Cytol; 2021; 38(3):158-163. PubMed ID: 34703093
[TBL] [Abstract][Full Text] [Related]
8. Utility of the Proposed Sydney System for Classification of Fine-Needle Aspiration Cytopathology of Lymph Node: A Retrospective Study at a Tertiary Care Center.
Kanhe R; Tummidi S; Kothari K; Agnihotri M
Acta Cytol; 2023; 67(5):455-467. PubMed ID: 37231736
[TBL] [Abstract][Full Text] [Related]
9. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
Wang M; Sun T; Jiao J; Wang H
Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the Sydney System for Reporting Lymph Node Fine-Needle Aspiration Biopsy in Diagnosing Malignancy.
Ahuja S; Aziz Khan A; Ahuja R; Ahuja P; Zaheer S
Acta Cytol; 2024; 68(1):13-25. PubMed ID: 38096796
[TBL] [Abstract][Full Text] [Related]
11. The importance of risk of neoplasm as an outcome in cytologic-histologic correlation studies on thyroid fine needle aspiration.
Chen YH; Partyka KL; Dougherty R; Cramer HM; Wu HH
Diagn Cytopathol; 2020 Dec; 48(12):1237-1243. PubMed ID: 32716614
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
13. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.
Yang H; Zhu J; Wang P
Medicine (Baltimore); 2023 Oct; 102(43):e35707. PubMed ID: 37904355
[TBL] [Abstract][Full Text] [Related]
14. Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy.
Shannon JJ; Bude RO; Orens JB; Becker FS; Whyte RI; Rubin JM; Quint LE; Martinez FJ
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1424-30. PubMed ID: 8616576
[TBL] [Abstract][Full Text] [Related]
15. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
Kopczyński J; Suligowska A; Niemyska K; Palyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
Endokrynol Pol; 2019; 70(3):232-236. PubMed ID: 30845342
[TBL] [Abstract][Full Text] [Related]
16. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.
Maleki Z; Baloch Z; Lu R; Shafique K; Song SJ; Viswanathan K; Rao RA; Lefler H; Fatima A; Wiles A; Jo VY; Wang H; Fadda G; Powers CN; Ali SZ; Pantanowitz L; Siddiqui MT; Nayar R; Klijanienko J; Barkan GA; Krane JF; Rossi ED; Callegari F; Kholová I; Bongiovanni M; Faquin WC; Pusztaszeri MP
Cancer Cytopathol; 2019 May; 127(5):306-315. PubMed ID: 31050186
[TBL] [Abstract][Full Text] [Related]
17. An institutional experience: A retrospective analysis of the effect of transitioning from follicular lesion of undetermined significance to atypia of undetermined significance with subclassified atypia on interobserver concordance, rates of neoplasia, and rates of malignancy.
Kroll-Wheeler L; Cantley R; Pang JC; Soles BS; Smola B; Jing X; Lew M
Diagn Cytopathol; 2021 Jan; 49(1):31-38. PubMed ID: 32936526
[TBL] [Abstract][Full Text] [Related]
18. Revised Bethesda System for Reporting Thyroid Cytology: Lessons learned from an appraisal of 5 years of experience in a central hospital.
El Hag IA; Johnston J; Alessa E; Al Shammari M
Cytopathology; 2021 Jul; 32(4):482-492. PubMed ID: 33772905
[TBL] [Abstract][Full Text] [Related]
19. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.
Mathur A; Najafian A; Schneider EB; Zeiger MA; Olson MT
Surgery; 2014 Dec; 156(6):1471-6; discussion1476. PubMed ID: 25218896
[TBL] [Abstract][Full Text] [Related]
20. Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China.
Zhao H; Guo H; Zhao L; Cao J; Sun Y; Wang C; Zhang Z
Cancer Cytopathol; 2021 Aug; 129(8):642-648. PubMed ID: 34139103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
